Three-dimensional conformal radiotherapy (3DCRT) combined with transcatheter arterial chemoembolization (TACE) for inoperable or unresectable hepatocellular carcinoma (HCC): Clinical phase I/II trial

被引：0
|
作者：
Jiang, G
Zhou, Z
Liu, L
机构：
[1] Fudan Univ, Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China
[2] Fudan Univ, Canc Hosp, Dept Integrat Chinese & Western Med, Shanghai 200433, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.277
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1027
引用
收藏
页码：S160 / S161
页数：2
相关论文
共 50 条
  • [41] Stereotactic body radiotherapy (SBRT) combined with transcatheter arterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) versus TACE and TKIs alone for unresectable hepatocellular carcinoma (uHCC) with portal vein tumor thrombus (PVTT): A randomized controlled trial
    Duan, Jiayu
    Zhou, Jitao
    Liu, Chang
    Jiang, Hanyu
    Zhou, Jin
    Xie, Kunlin
    Wu, Hong
    Zeng, Yong
    Wang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC):: Significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy
    Lubienski, A
    Bitsch, RG
    Schemmer, P
    Grenacher, L
    Düx, M
    Kauffmann, GW
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2004, 176 (12): : 1794 - 1802
  • [43] Three-dimensional conformal radiotherapy (3D-CRT) for macroscopic vascular invasion (MVO of advanced hepatocellular carcinoma (HCC).
    Asagi, Akinori
    Ishii, Hiroshi
    Uesugi, Kazuhiro
    Nadano, Seijin
    Kajiwara, Takeshi
    Tanimizu, Masahito
    Nishikawa, Atsushi
    Ochi, Takashi
    Hamamoto, Yasushi
    Kataoka, Masaaki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Clinical results of three-dimensional conformal radiotherapy for portal vein or inferior vena cava tumor thrombus in patients with inoperable hepatocellular carcinoma
    Maeda, S.
    Hayashi, H.
    Tanaka, O.
    Matsuo, M.
    Kanematsu, M.
    Goshima, S.
    Kondo, H.
    Hoshi, H.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S524 - S524
  • [45] THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AND INTENSITY-MODULATED RADIATION THERAPY COMBINED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA: AN IRRADIATION DOSE ESCALATION STUDY
    Ren, Zhi-Gang
    Zhao, Jian-Dong
    Gu, Ke
    Chen, Zhen
    Lin, Jun-Hua
    Xu, Zhi-Yong
    Hu, Wei-Gang
    Zhou, Zhen-Hua
    Liu, Lu-Ming
    Jiang, Guo-Liang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 496 - 502
  • [46] Phase II Study of Docetaxel (Aisu®) Combined with Three-dimensional Conformal External Beam Radiotherapy in Treating Patients with Inoperable Esophageal Cancer
    Shen, Kang
    Huang, Xin-En
    Lu, Yan-Yan
    Wu, Xue-Yan
    Liu, Jin
    Xiang, Jin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6523 - 6526
  • [47] Association of radiation and tissue homeostasis response gene polymorphisms with clinical late toxicity in patients treated with three-dimensional conformal radiotherapy (3DCRT) for adenocarcinoma of the prostate
    Parliament, M
    Damaraju, S
    Murray, D
    Dufour, J
    Myrehaug, S
    Anderson, S
    Fallone, G
    Field, C
    Greiner, R
    Menard, C
    Hanson, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S25 - S25
  • [48] Single nucleotide polymorphisms in radiation response genes correlate with clinical late toxicity in patients treated with three-dimensional conformal radiotherapy (3DCRT) for adenocarcinoma of the prostate
    Parliament, M
    Damaraju, S
    Murray, D
    Dufour, J
    Myrehaug, S
    Greiner, W
    Fallone, G
    Field, C
    Menard, C
    Hanson, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S23 - S23
  • [49] Phase I clinical trial of oral Furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers, including clinicopathologic study
    Zeng, ZC
    Tang, ZY
    Wu, ZQ
    Ma, ZC
    Fan, J
    Qin, LX
    Zhou, J
    Wang, JH
    Wang, BL
    Zhong, CS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (05): : 449 - 454
  • [50] TACTICS: Final overall survival (OS) data from a randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients (pts) with hepatocellular carcinoma (HCC)
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Ikeda, Masafumi
    Torimura, Takuji
    Aikata, Hiroshi
    Izumi, Namiki
    Yamasaki, Takahiro
    Hino, Keisuke
    Kuzuya, Teiji
    Isoda, Norio
    Yasui, Kohichiroh
    Aino, Hajime
    Ido, Akio
    Kawabe, Naoto
    Nakao, Kazuhiko
    Wada, Yoshiyuki
    Yoshimura, Kenichi
    Okusaka, Takuji
    Furuse, Junji
    Arai, Yasuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
12345